Immunis

Immunis, Inc. is a private, clinical-stage biotechnology company headquartered in Irvine, California, developing immunomodulatory secretome biologics — the mixture of proteins and factors secreted by stem cells, rather than the cells themselves — as a treatment for age- and disease-related immune decline. Its lead candidate, IMM01-STEM, is under study in the STEM-MYO Phase 1/2a trial for muscle atrophy and sarcopenia, alongside a STEM-META Phase 2 program and a STEM-K9 veterinary program. Immunis is a therapeutics developer, not a software company: it publishes no developer portal, API, SDK, webhook surface, or machine-readable API contract of any kind. Its entire public surface is a WordPress marketing and clinical-trial-recruitment site whose only machine-readable endpoint is the default WordPress REST API at /wp-json/, which serves the CMS of that site and is not an Immunis API product.

Immunis is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Clinical Trials.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0

0 APIs

Company Biotechnology Life Sciences Therapeutics Clinical Trials Regenerative Medicine Healthcare LongevitySarcopenia

Kin Score

Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/immunis: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

PressReleases

PressReleases

Contact

Contact

Company 2

The organization behind the API

Website

Website

LinkedIn

Source (apis.yml)

aid: immunis
name: Immunis
description: 'Immunis, Inc. is a private, clinical-stage biotechnology company headquartered in Irvine, California, developing
  immunomodulatory secretome biologics — the mixture of proteins and factors secreted by stem cells, rather than the cells
  themselves — as a treatment for age- and disease-related immune decline. Its lead candidate, IMM01-STEM, is under study
  in the STEM-MYO Phase 1/2a trial for muscle atrophy and sarcopenia, alongside a STEM-META Phase 2 program and a STEM-K9
  veterinary program. Immunis is a therapeutics developer, not a software company: it publishes no developer portal, API,
  SDK, webhook surface, or machine-readable API contract of any kind. Its entire public surface is a WordPress marketing and
  clinical-trial-recruitment site whose only machine-readable endpoint is the default WordPress REST API at /wp-json/, which
  serves the CMS of that site and is not an Immunis API product.'
image: https://immunisbiomedical.com/wp-content/uploads/2026/06/ImmunisLogo.png
url: https://raw.githubusercontent.com/api-evangelist/immunis/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Life Sciences
- Therapeutics
- Clinical Trials
- Regenerative Medicine
- Healthcare
- Longevity
- Sarcopenia
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/immunis-domain-security.yml
- type: LLMsTxt
  url: llms/immunis-llms.txt
- type: Website
  url: https://immunisbiomedical.com/
- type: PressReleases
  url: https://immunisbiomedical.com/press-releases/
- type: Contact
  url: https://immunisbiomedical.com/contact/
- type: LinkedIn
  url: https://www.linkedin.com/company/immunisbiomedical/
x-enrichment:
  date: '2026-08-23'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Immunis, Inc. is a clinical-stage biotech developing secretome therapeutics; its full page inventory (46 pages,
    read from the site's own sitemap) contains no developer, API or documentation page, and every /openapi.json, /api-docs,
    /graphql, /llms.txt and /.well-known/* probe on immunisbiomedical.com returned the WordPress 404 page — the only machine-readable
    endpoint on the host is the site's default WordPress CMS REST API at /wp-json/.
  evidence:
  - url: https://immunisbiomedical.com/openapi.json
    status: 404
  - url: https://immunisbiomedical.com/.well-known/api-catalog
    status: 404
  - url: https://immunisbiomedical.com/llms.txt
    status: 404
  - url: https://immunisbiomedical.com/developers
    status: 404
  - url: https://immunisbiomedical.com/wp-json/
    status: 200
  checked: '2026-08-23'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/immunis"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/immunis/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/immunis/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.